Clinical trial
A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to…
NCT00162084 · Forest Laboratories, Industry · Terminated
Key facts
| NCT number | NCT00162084 |
|---|---|
| Title | A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography |
| Official title | A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Disease, Ischemic Heart Disease |
| Intervention type | Drug |
| Interventions | apadenoson |
| Enrollment | 2,000 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2006 |
| First posted | Sep 13, 2005 |
| Last update posted | Feb 1, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: